Annual FCF
-$39.34 M
-$20.81 M-112.26%
December 31, 2023
Summary
- As of February 8, 2025, ITRM annual free cash flow is -$39.34 million, with the most recent change of -$20.81 million (-112.26%) on December 31, 2023.
- During the last 3 years, ITRM annual FCF has risen by +$15.20 million (+27.86%).
- ITRM annual FCF is now -248.23% below its all-time high of -$11.30 million, reached on December 31, 2016.
Performance
ITRM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$2.67 M
+$4.09 M+60.48%
September 30, 2024
Summary
- As of February 8, 2025, ITRM quarterly free cash flow is -$2.67 million, with the most recent change of +$4.09 million (+60.48%) on September 30, 2024.
- Over the past year, ITRM quarterly FCF has stayed the same.
- ITRM quarterly FCF is now -136.04% below its all-time high of -$1.13 million, reached on March 31, 2021.
Performance
ITRM Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$35.36 M
+$6.59 M+15.71%
September 30, 2024
Summary
- As of February 8, 2025, ITRM TTM free cash flow is -$35.36 million, with the most recent change of +$6.59 million (+15.71%) on September 30, 2024.
- Over the past year, ITRM TTM FCF has stayed the same.
- ITRM TTM FCF is now -493.97% below its all-time high of -$5.95 million, reached on March 31, 2017.
Performance
ITRM TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
ITRM Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -112.3% | 0.0% | 0.0% |
| 3 y3 years | +27.9% | 0.0% | 0.0% |
| 5 y5 years | +49.1% | 0.0% | 0.0% |
ITRM Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -147.4% | at low | -8.1% | +79.6% | -122.3% | +17.4% |
| 5 y | 5-year | -147.4% | +52.0% | -136.0% | +90.2% | -122.3% | +62.5% |
| alltime | all time | -248.2% | +52.0% | -136.0% | +90.3% | -494.0% | +62.5% |
Iterum Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.67 M(-60.5%) | -$35.36 M(-15.7%) |
| Jun 2024 | - | -$6.76 M(-48.3%) | -$41.95 M(-2.1%) |
| Mar 2024 | - | -$13.08 M(+1.9%) | -$42.84 M(+8.9%) |
| Dec 2023 | -$39.34 M(+112.3%) | -$12.84 M(+38.7%) | -$39.34 M(+27.7%) |
| Sep 2023 | - | -$9.26 M(+21.1%) | -$30.81 M(+18.1%) |
| Jun 2023 | - | -$7.65 M(-20.3%) | -$26.09 M(+5.6%) |
| Mar 2023 | - | -$9.59 M(+122.5%) | -$24.72 M(+33.4%) |
| Dec 2022 | -$18.54 M(+16.6%) | -$4.31 M(-5.2%) | -$18.54 M(+11.0%) |
| Sep 2022 | - | -$4.55 M(-27.5%) | -$16.70 M(+3.7%) |
| Jun 2022 | - | -$6.27 M(+84.3%) | -$16.11 M(-11.4%) |
| Mar 2022 | - | -$3.40 M(+37.7%) | -$18.18 M(+14.3%) |
| Dec 2021 | -$15.90 M(-70.8%) | -$2.47 M(-37.5%) | -$15.90 M(-29.2%) |
| Sep 2021 | - | -$3.96 M(-52.5%) | -$22.46 M(-2.0%) |
| Jun 2021 | - | -$8.34 M(+636.8%) | -$22.93 M(-18.9%) |
| Mar 2021 | - | -$1.13 M(-87.5%) | -$28.28 M(-48.1%) |
| Dec 2020 | -$54.54 M | -$9.03 M(+104.0%) | -$54.54 M(-20.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$4.43 M(-67.7%) | -$68.56 M(-23.4%) |
| Jun 2020 | - | -$13.69 M(-50.0%) | -$89.55 M(-5.0%) |
| Mar 2020 | - | -$27.39 M(+18.8%) | -$94.27 M(+15.0%) |
| Dec 2019 | -$81.95 M(+6.0%) | -$23.05 M(-9.3%) | -$81.95 M(-2.6%) |
| Sep 2019 | - | -$25.41 M(+38.0%) | -$84.10 M(-2.4%) |
| Jun 2019 | - | -$18.42 M(+22.3%) | -$86.20 M(+6.8%) |
| Mar 2019 | - | -$15.06 M(-40.2%) | -$80.74 M(+4.4%) |
| Dec 2018 | -$77.34 M(+146.2%) | -$25.21 M(-8.4%) | -$77.34 M(+24.1%) |
| Sep 2018 | - | -$27.51 M(+112.2%) | -$62.30 M(+54.3%) |
| Jun 2018 | - | -$12.96 M(+11.2%) | -$40.38 M(+8.8%) |
| Mar 2018 | - | -$11.66 M(+14.7%) | -$37.12 M(+18.2%) |
| Dec 2017 | -$31.42 M(+178.1%) | -$10.17 M(+81.9%) | -$31.42 M(+47.9%) |
| Sep 2017 | - | -$5.59 M(-42.4%) | -$21.25 M(+35.7%) |
| Jun 2017 | - | -$9.70 M(+63.0%) | -$15.66 M(+163.0%) |
| Mar 2017 | - | -$5.95 M | -$5.95 M |
| Dec 2016 | -$11.30 M | - | - |
FAQ
- What is Iterum Therapeutics annual free cash flow?
- What is the all time high annual FCF for Iterum Therapeutics?
- What is Iterum Therapeutics annual FCF year-on-year change?
- What is Iterum Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Iterum Therapeutics?
- What is Iterum Therapeutics quarterly FCF year-on-year change?
- What is Iterum Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Iterum Therapeutics?
- What is Iterum Therapeutics TTM FCF year-on-year change?
What is Iterum Therapeutics annual free cash flow?
The current annual FCF of ITRM is -$39.34 M
What is the all time high annual FCF for Iterum Therapeutics?
Iterum Therapeutics all-time high annual free cash flow is -$11.30 M
What is Iterum Therapeutics annual FCF year-on-year change?
Over the past year, ITRM annual free cash flow has changed by -$20.81 M (-112.26%)
What is Iterum Therapeutics quarterly free cash flow?
The current quarterly FCF of ITRM is -$2.67 M
What is the all time high quarterly FCF for Iterum Therapeutics?
Iterum Therapeutics all-time high quarterly free cash flow is -$1.13 M
What is Iterum Therapeutics quarterly FCF year-on-year change?
Over the past year, ITRM quarterly free cash flow has changed by $0.00 (0.00%)
What is Iterum Therapeutics TTM free cash flow?
The current TTM FCF of ITRM is -$35.36 M
What is the all time high TTM FCF for Iterum Therapeutics?
Iterum Therapeutics all-time high TTM free cash flow is -$5.95 M
What is Iterum Therapeutics TTM FCF year-on-year change?
Over the past year, ITRM TTM free cash flow has changed by $0.00 (0.00%)